Atlas FDA

MEDTRONIC INTERSTIM THERAPY

FDA premarket approval P970004/S049 · decided 2008-04-24

Approval details

PMA number
P970004
Supplement
S049
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
MEDTRONIC INTERSTIM THERAPY
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2008-02-26
Decision date
2008-04-24
Days to decision
58 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR LABELING CHANGES TO THE TECHNICAL MANUAL FOR THE TEST STIMULATION LEAD KIT AND TEST STIMULATION LEAD (MODEL 3065U AND MODEL 3057, RESPECTIVELY) TO EXPLICITLY DESCRIBE THE PRACTICE OF IMPLANTING TWO TEMPORARY TEST STIMULATION LEADS DURING A SINGLE BILATERAL PLACEMENT PROCEDURE FOR SEQUENTIAL TESTING WITHIN THE SEVEN DAY TRIAL PERIOD.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23